Medical diagnostics company Omega said it expects to report turnover up five per cent to £4.46 million in its six months to 30 September. In a trading update the Alva-based business, which focuses on allergy, food intolerance and infectious disease, said it expected a “minimal currency effect” between revenues for the first half period compared. For the full article, please see here: https://www.insider.co.uk/company-results-forecasts/medical-diagnostics-company-expects-turnover-20670600
A new imaging technology tool which detects key cells involved in the formation of secondary tumours, has been developed by researchers at the University of Edinburgh. It is hoped the new type of chemical probe could lead to earlier diagnosis and treatment for cancer patients. As well as examining the cells involved in the development of secondary tumours – known as metastatic tumours – the probe...
MIME Technologies has announced that the team have secured new investment and an additional Scottish Enterprise SMART grant. The investment, led by Equity Gap and the Scottish Investment Bank, will be used to accelerate growth and create new operational and technical jobs. MIME® is the product of five-years of research and development, funded by the RCUK Digital Economy Programme, the Digital Health & Care Institute and Highland &...
A blood test which could help to accelerate the diagnosis of brain cancer has been developed in research led at the University of Strathclyde. The patented technology uses infrared light to produce a “bio-signature” of a blood sample and applies artificial intelligence to check for the signs of cancer. This research is being commercialised by ClinSpec Diagnostics Limited, an award-winning company spun out from the University in...
Invizius, the University of Edinburgh spin-out whose technology could help reduce the high death rates amongst dialysis patients, has raised £2.75m from a consortium of investors. The funding round was led by Mercia and included Downing Ventures, the University’s Old College Capital fund and the Scottish Investment Bank. The latest investment will support the company as it conducts pre-clinical testing and manufacturing, and prepares to...
Omega Diagnostics Group PLC said Monday it swung to a profit following the divestment of several businesses, even as this led to a decline in revenue. Also, the medical diagnostics group announced that it would raise GBP1.7 million through both a placing and subscription, which will go towards working capital purposes, and commercialising both versions of the Visitect CD4 test. Omega Diagnostics will issue 16.4...